Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The National Amyotrophic Lateral Sclerosis (ALS) Registry patient guide
  • Published Date:
    6/13/12
  • Language:
    English
Filetype[PDF-3.05 MB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013
    Personal Author:
    Horton, D. Kevin; Graham, Shannon; Punjani, Reshma; Wilt, Grete; Kaye, Wendy; Maginnis, Kimberly; Webb, Lauren; Richman, Judy; Bedlack, Richard; Tessaro, Edward; Mehta, Paul;
    Published Date:
    Dec 20 2017
    Source:
    Amyotroph Lateral Scler Frontotemporal Degener. 19(1-2):126-133.
    Description:
    BackgroundAmyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease that typically results in death within 2–5 years of initial symptom onset. Multidisciplinary ALS clinics (MDCs) have been established to provide specialty care to people ...
    File Type:
    Filetype[PDF - 85.48 KB]
  2. A National assessment of amyotrophic lateral sclerosis and other chronic neurologic conditions state surveillance programs : a report for the Agency for Toxic Substances and Disease Registry (ATSDR)
    Personal Author:
    Chao, Ed; Simms, Erin;
    Corporate Authors:
    Council of State and Territorial Epidemiologists.. United States. Agency for Toxic Substances and Disease Registry..
    Published Date:
    June 6, 2009
    Description:
    On October 8, 2008, the President signed the ALS Registry Act (Public Law No. 110- 373) into law. It authorizes the Centers for Disease Control and Prevention (CDC) to establish a national amyotrophic lateral sclerosis (ALS) patient registry to ident...
    File Type:
    Filetype[PDF - 110.06 KB]
  3. Evaluating the completeness of the national ALS registry, United States
    Personal Author:
    KAYE, WENDY E.; WAGNER, LAURIE; WU, RUOMING; MEHTA, PAUL;
    Published Date:
    Oct 11 2017
    Source:
    Amyotroph Lateral Scler Frontotemporal Degener. 19(1-2):112-117.
    Description:
    Our objective was to evaluate the completeness of the United States National ALS Registry (Registry). We compared persons with ALS who were passively identified by the Registry with those actively identified in the State and Metropolitan Area ALS Sur...
    File Type:
    Filetype[PDF - 78.69 KB]
  4. Summary report : Amyotrophic Lateral Sclerosis and Multiple Sclerosis Surveillance annual meeting : February 26, 2008 : Issues related to developing a national surveillance system and registries for amyotrophic lateral sclerosis and multiple sclerosis
    Corporate Authors:
    United States. Agency for Toxic Substances and Disease Registry.
    Published Date:
    2008
    Description:
    This document has not been revised or edited to conform to agency standards. The findings and conclusions in this report are those of the meeting presenters and attendees and do not necessarily represent the views of the Agency for Toxic Substances a...
    File Type:
    Filetype[PDF - 678.96 KB]
  5. CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions
    Personal Author:
    Mehta, Paul; Horton, D. Kevin; Kasarskis, Edward J.; Tessaro, Ed; Eisenberg, M. Shira; Laird, Susan; Iskander, John;
    Published Date:
    Dec 22 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(50):1379-1382.
    Description:
    Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a rapidly progressive fatal neurologic disease. Currently, there is no cure for ALS and the available treatments only extend life by an average of a few months. The major...
    File Type:
    Filetype[PDF - 107.88 KB]